ChEBI

CHEBI:67165 - α-L-Fuc-(1→3)-[β-D-Gal-(1→4)]-β-D-GlcNAc-(1→2)-α-D-Man-(1→3)-[α-L-Fuc-(1→3)-[β-D-Gal-(1→4)]-β-D-GlcNAc-(1→2)-α-D-Man-(1→6)]-β-D-Man-(1→4)-β-D-GlcNAc-(1→4)-β-D-GlcNAc

ChEBI Name α-L-Fuc-(1→3)-[β-D-Gal-(1→4)]-β-D-GlcNAc-(1→2)-α-D-Man-(1→3)-[α-L-Fuc-(1→3)-[β-D-Gal-(1→4)]-β-D-GlcNAc-(1→2)-α-D-Man-(1→6)]-β-D-Man-(1→4)-β-D-GlcNAc-(1→4)-β-D-GlcNAc ChEBI ID CHEBI:67165 ChEBI ASCII Name alpha-L-Fuc-(1->3)-[beta-D-Gal-(1->4)]-beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->3)-[alpha-L-Fuc-(1->3)-[beta-D-Gal-(1->4)]-beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->6)]-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-beta-D-GlcNAc Definition An oligosaccharide derivative that is an undecasaccharide in which two tetrasaccharide branches, each formed from α-L-fucosyl-(1→3)-[β-D-galactosyl-(1→4)]-N-acetyl-β-D-glucosaminyl-(1→2)-α-D-mannose, are linked (1→3) and (1→6) to the mannose residue of a trisaccharide chain consisting of mannose and two N-acetylglucosamine residues all linked β(1→4) with a β-configuration of the anomeric carbon of the N-acetylglucosamine residue at the reducing end. Stars This entity has been manually annotated by the ChEBI Team. Supplier Information Download Molfile XML SDF Find compounds which contain this structure Find compounds which resemble this structure Take structure to the Advanced Search Formula C74H124N4O54 Net Charge 0 Average Mass 1933.77080 Monoisotopic Mass 1932.70799 InChI InChI=1S/C74H124N4O54/c1-16-35(91)44(100)50(106)68(113-16)128-59-33(77-20(5)89)66(121-28(13-85)57(59)126-70-52(108)46(102)37(93)22(7-79)116-70)131-62-48(104)39(95)24(9-81)118-73(62)112-15-30-41(97)61(54(110)72(123-30)125-56-27(12-84)120-65(32(43(56)99)76-19(4)88)124-55-26(11-83)115-64(111)31(42(55)98)75-18(3)87)130-74-63(49(105)40(96)25(10-82)119-74)132-67-34(78-21(6)90)60(129-69-51(107)45(101)36(92)17(2)114-69)58(29(14-86)122-67)127-71-53(109)47(103)38(94)23(8-80)117-71/h16-17,22-74,79-86,91-111H,7-15H2,1-6H3,(H,75,87)(H,76,88)(H,77,89)(H,78,90)/t16-,17-,22+,23+,24+,25+,26+,27+,28+,29+,30+,31+,32+,33+,34+,35+,36+,37-,38-,39+,40+,41+,42+,43+,44+,45+,46-,47-,48-,49-,50-,51-,52+,53+,54-,55+,56+,57+,58+,59+,60+,61-,62-,63-,64+,65-,66-,67-,68-,69-,70-,71-,72-,73-,74+/m0/s1 InChIKey NBHYRALEXIBZFJ-ZRIWBAKZSA-N SMILES C[C@@H]1O[C@@H](O[C@@H]2[C@@H](NC(C)=O)[C@@H](O[C@H](CO)[C@H]2O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)O[C@H]2[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]2OC[C@H]2O[C@@H](O[C@H]3[C@H](O)[C@@H](NC(C)=O)[C@@H](O[C@@H]3CO)O[C@H]3[C@H](O)[C@@H](NC(C)=O)[C@H](O)O[C@@H]3CO)[C@@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]3O[C@@H]3O[C@H](CO)[C@@H](O[C@@H]4O[C@H](CO)[C@H](O)[C@H](O)[C@H]4O)[C@H](O[C@@H]4O[C@@H](C)[C@@H](O)[C@@H](O)[C@@H]4O)[C@H]3NC(C)=O)[C@@H]2O)[C@@H](O)[C@H](O)[C@@H]1O Roles Classification Biological Role(s): epitope The biological role played by a material entity when bound by a receptor of the adaptive immune system. Specific site on an antigen to which an antibody binds. (via alpha-L-Fuc-(1->3)-[beta-D-Gal-(1->4)]-beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->3)-[alpha-L-Fuc-(1->3)-[beta-D-Gal-(1->4)]-beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->6)]-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-beta-D-GlcNAc ) View more via ChEBI Ontology ChEBI Ontology Outgoing α-L-Fuc-(1→3)-[β-D-Gal-(1→4)]-β-D-GlcNAc-(1→2)-α-D-Man-(1→3)-[α-L-Fuc-(1→3)-[β-D-Gal-(1→4)]-β-D-GlcNAc-(1→2)-α-D-Man-(1→6)]-β-D-Man-(1→4)-β-D-GlcNAc-(1→4)-β-D-GlcNAc (CHEBI:67165) has role epitope (CHEBI:53000) α-L-Fuc-(1→3)-[β-D-Gal-(1→4)]-β-D-GlcNAc-(1→2)-α-D-Man-(1→3)-[α-L-Fuc-(1→3)-[β-D-Gal-(1→4)]-β-D-GlcNAc-(1→2)-α-D-Man-(1→6)]-β-D-Man-(1→4)-β-D-GlcNAc-(1→4)-β-D-GlcNAc (CHEBI:67165) is a amino oligosaccharide (CHEBI:22483) α-L-Fuc-(1→3)-[β-D-Gal-(1→4)]-β-D-GlcNAc-(1→2)-α-D-Man-(1→3)-[α-L-Fuc-(1→3)-[β-D-Gal-(1→4)]-β-D-GlcNAc-(1→2)-α-D-Man-(1→6)]-β-D-Man-(1→4)-β-D-GlcNAc-(1→4)-β-D-GlcNAc (CHEBI:67165) is a glucosamine oligosaccharide (CHEBI:22485) IUPAC Name α-L-fucopyranosyl-(1→3)-[β-D-galactopyranosyl-(1→4)]-2-acetamido-2-deoxy-β-D-glucopyranosyl-(1→2)-α-D-mannopyranosyl-(1→3)-[6-deoxy-α-L-galactopyranosyl-(1→3)-[β-D-galactopyranosyl-(1→4)]-2-acetamido-2-deoxy-β-D-glucopyranosyl-(1→2)-α-D-mannopyranosyl-(1→6)]-β-D-mannopyranosyl-(1→4)-2-acetamido-2-deoxy-β-D-glucopyranosyl-(1→4)-2-acetamido-2-deoxy-β-D-glucopyranose Synonyms Sources 6-deoxy-α-L-galactopyranosyl-(1→3)-[β-D-galactopyranosyl-(1→4)]-2-acetamido-2-deoxy-β-D-glucopyranosyl-(1→2)-α-D-mannopyranosyl-(1→3)-[6-deoxy-α-L-galactopyranosyl-(1→3)-[β-D-galactopyranosyl-(1→4)]-2-acetamido-2-deoxy-β-D-glucopyranosyl-(1→2)-α-D-mannopyranosyl-(1→6)]-β-D-mannopyranosyl-(1→4)-2-acetamido-2-deoxy-β-D-glucopyranosyl-(1→4)-2-acetamido-2-deoxy-β-D-glucopyranose IUPAC α-L-fucosyl-(1→3)-[β-D-galactosyl-(1→4)]-N-acetyl-β-D-glucosaminyl-(1→2)-α-D-mannosyl-(1→3)-[α-L-fucosyl-(1→3)-[β-D-galactosyl-(1→4)]-N-acetyl-β-D-glucosaminyl-(1→2)-α-D-mannosyl-(1→6)]-β-D-mannosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→4)-N-acetyl-β-D-glucosamine ChEBI α-L-Fucp-(1→3)-[β-D-Galp-(1→4)]-β-D-GlcpNAc-(1→2)-α-D-Manp-(1→3)-[α-L-Fucp-(1→3)-[β-D-Galp-(1→4)]-β-D-GlcpNAc-(1→2)-α-D-Man-p(1→6)]-β-D-Manp-(1→4)-β-D-GlcpNAc-(1→4)-β-D-GlcpNAc JCBN Fucα1-3(Galβ1-4)GlcNAcβ1-2Manα1-3(Fucα1-3(Galβ1-4)GlcNAcβ1-2Manα1-6)Manβ1-4GlcNAcβ1-4GlcNAcβ ChEBI Galb1-4(Fuca1-3)GlcNAcb1-2Mana1-3(Galb1-4(Fuca1-3)GlcNAcb1-2Mana1-6)Manb1-4GlcNAcb1-4GlcNAcb ChEBI Galb1-4(Fuca1-3)GlcNAcb1-2Mana1-6(Galb1-4(Fuca1-3)GlcNAcb1-2Mana1-3)Manb1-4GlcNAcb1-4GlcNAcb ChEBI Galβ1-4(Fucα1-3)GlcNAcβ1-2Manα1-3(Galβ1-4(Fucα1-3)GlcNAcβ1-2Manα1-6)Manβ1-4GlcNAcβ1-4GlcNAcβ ChEBI Galβ1-4(Fucα1-3)GlcNAcβ1-2Manα1-6(Galβ1-4(Fucα1-3)GlcNAcβ1-2Manα1-3)Manβ1-4GlcNAcβ1-4GlcNAcβ ChEBI O-6-deoxy-α-L-galactopyranosyl-(1→3)-O-[β-D-galactopyranosyl-(1→4)]-O-2-(acetylamino)-2-deoxy-β-D-glucopyranosyl-(1→2)-O-α-D-mannopyranosyl-(1→3)-O-[O-6-deoxy-α-L-galactopyranosyl-(1→3)-O-[β-D-galactopyranosyl-(1→4)]-O-2-(acetylamino)-2-deoxy-β-D-glucopyranosyl-(1→2)-α-D-mannopyranosyl-(1→6)]-O-β-D-mannopyranosyl-(1→4)-O-2-(acetylamino)-2-deoxy-β-D-glucopyranosyl-(1→4)-2-(acetylamino)-2-deoxy-β-D-glucopyranose ChEBI WURCS=2.0/5,11,10/[a2122h-1b_1-5_2*NCC/3=O][a1122h-1b_1-5][a1122h-1a_1-5][a1221m-1a_1-5][a2112h-1b_1-5]/1-1-2-3-1-4-5-3-1-4-5/a4-b1_b4-c1_c3-d1_c6-h1_d2-e1_e3-f1_e4-g1_h2-i1_i3-j1_i4-k1 GlyTouCan Manual Xrefs Databases G25407RZ GlyGen G25407RZ GlyTouCan View more database links Citations Types Sources 19443021 PubMed citation Europe PMC 31537530 PubMed citation Europe PMC 32568414 PubMed citation Europe PMC Last Modified 20 February 2023